8-Epidiosbulbin E acetate
CAS No. 91095-48-6
8-Epidiosbulbin E acetate ( —— )
Catalog No. M24951 CAS No. 91095-48-6
8-Epidiosbulbin E acetate exhibits broad-spectrum plasmid-curing activity against multidrug-resistant (MDR) bacteria, including vancomycin-resistant enterococci.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 195 | In Stock |
|
10MG | 288 | In Stock |
|
25MG | 484 | In Stock |
|
50MG | 701 | In Stock |
|
100MG | 981 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product Name8-Epidiosbulbin E acetate
-
NoteResearch use only, not for human use.
-
Brief Description8-Epidiosbulbin E acetate exhibits broad-spectrum plasmid-curing activity against multidrug-resistant (MDR) bacteria, including vancomycin-resistant enterococci.
-
Description8-Epidiosbulbin E acetate exhibits broad-spectrum plasmid-curing activity against multidrug-resistant (MDR) bacteria, including vancomycin-resistant enterococci.
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetAntifection
-
RecptorAnti-infection
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number91095-48-6
-
Formula Weight388.4
-
Molecular FormulaC21H24O7
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC[C@](C[C@@H](c1cocc1)O1)([C@H](C[C@H](C[C@H]23)OC2=O)[C@@H]3[C@H](C2)OC(C)=O)[C@H]2C1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.A potential plasmid-curing agent, 8-epidiosbulbin E acetate, from Dioscorea bulbifera L. against multidrug-resistant bacteria.Int J Antimicrob Agents. 2008 Nov;32(5):405-10.
molnova catalog
related products
-
Quercetin-3-O-β-D-gl...
Quercetin-3-O-β-D-glucose-7-O-β-D-gentiobiosiden is a flavonoid from Quercetin.
-
25-PYRIDINEDICARBOXY...
25-Pyridinedicarboxylic Acid is used in the preparation of new derivatives as antiviral agents.
-
26Rfa, Hypothalamic ...
This human neuropeptide of the RFamide peptide family with orexigenic activity may be also involved in the control of feeding behavior. The 26RFa gene is exclusively expressed in the ventromedial hypothalamic nucleus and in the lateral hypothalamic area. The primary structures of human, rat, and frog 26RFa exhibit ≈80% identity. Other data suggest also the potential role of the 26RFa peptide in the control of the gonadotropic axis.